Missing/wrong data?
Log in to edit
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
scientific article published on 14 May 2009
Author/s
author: Krzysztof Giannopoulos, Ewa Wasik-Szczepanek, Agnieszka Bojarska-Junak, Jacek Roliński, Jacek Roliński, Anna Dmoszyńska
Work details
Publication date
May 14, 2009
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.